Northbank Communications

Case Studies / Novozymes BioPharma UK

Re-branding and Re-positioning Novozymes Biopharma UK

Novozymes Biopharma UK (formerly Delta Biotechnology Ltd) is a subsidiary of Novozymes. In response to increasing restrictions on the use of animal-derived products in biopharmaceutical manufacture, Novozymes Biopharma has developed dedicated animal-free recombinant products that bring consistency, compliance and productivity to customers' biotherapeutic manufacturing processes.

Our Task

Re-brand current marketing materials using new brand guidelines
Develop a specific look and feel for Novozymes Biopharma across its products and services within the guidelines

Our Methods

Create distinct look and feel for Novozymes Biopharma using the corporate guidelines, across various marketing materials
Apply new style to the family of brochures and additional materials
Copywriting to ensure messages are adapted to fit within the guidelines and brand values
Commission and direct new product-focussed photography
Project and print management to meet tight deadlines

Results

Production of brochures, exhibition stands and direct mail pieces
Launch at Bioprocess International Conference in North America, November 2007
The new materials were very well received and have aided the repositioning of the company

Client Endorsement

Maree Devine, Marketing Communications Manager at Novozymes Biopharma UK said: "We were very pleased with our new marketing collateral. Northbanks previous experience in rebranding our materials ensured a deep understanding and expertise of the Novozymes brand and enabled us to meet our extremely tight deadline."

October 2007

To discuss our capability in this area please contact:
Chris Fisher, Creative Director
+44 (0)1260 296 50
c.fisher[at]northbankcommunications.com

Credits
This project was implemented by Chris Fisher, Peter Colley, Tracy Williamson, Leslie Clark, Steve Arnold and Ben Routley.

	other clients